Efficacy and safety of avelumab plus axitinib (A plus Ax) versus sunitinib (S) in elderly patients with advanced renal cell carcinoma (aRCC): Extended follow-up results from JAVELIN Renal 101 Meeting Abstract


Authors: Tomita, Y.; Motzer, R. J.; Choueiri, T. K.; Rini, B. I.; Miyake, H.; Uemura, H.; Albiges, L.; Fujii, Y.; Umeyama, Y.; Wang, J.; Mariani, M.; Schmidinger, M.
Abstract Title: Efficacy and safety of avelumab plus axitinib (A plus Ax) versus sunitinib (S) in elderly patients with advanced renal cell carcinoma (aRCC): Extended follow-up results from JAVELIN Renal 101
Meeting Title: 2021 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 6 Suppl.
Meeting Dates: 2021 Feb 11-13
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-02-20
Language: English
ACCESSION: WOS:000636801500316
DOI: 10.1200/JCO.2021.39.6_suppl.301
PROVIDER: wos
Notes: Meeting Abstract: 301 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer